812.21 HMGLPTHLATER

CH

Art. 32 Bundesgesetz vom 15. Dezember 2000 über Arzneimittel und Medizinprodukte (HMG) - Unzulässige Werbung

HMG; 2. Kapitel: Arzneimittel

Originalquelle öffnen Gesamter Erlass (141 Artikel) Maschinenlesbares Markdown (.md)

Art. 32 HMG · Unzulässige Werbung

Unzulässig ist Werbung: a. die irreführend ist oder der öffentlichen Ordnung und den guten Sitten widerspricht; b. die zu einem übermässigen, missbräuchlichen oder unzweckmässigen Einsatz von Arzneimitteln verleiten kann; c. für Arzneimittel, die weder national noch kantonal in Verkehr gebracht werden dürfen.

Unzulässig ist Publikumswerbung für Arzneimittel, die: a. nur auf ärztliche Verschreibung abgegeben werden dürfen; b. Betäubungsmittel oder psychotrope Stoffe im Sinne des Betäubungsmittelgesetzes vom 3. Oktober 1951 enthalten; c. nach ihrer Zusammensetzung und Zweckbestimmung so beschaffen sind, dass sie ohne ärztliches Tätigwerden für die entsprechende Diagnose, Verschreibung oder Behandlung nicht verwendet werden können; d. häufig missbraucht werden oder zu Gewöhnung und Abhängigkeit führen können.

← Art. 31 HMG Bundesgesetz vom 15. Dezember 2000 über Arzneimittel und Medizinprodukte (HMG) - Zweck Art. 33 HMG →

Gerichtsentscheide zu dieser Bestimmung (22)

VWBES.2004.60 · so (Art. 32 Abs. 2 lit. a HMG)

Apothecary's Hormone Ointment: Market Authorization vs. Magistral Preparation

This provision was cited by the court to justify that advertising an item as a prescription drug is impermissible.

C-3035/2022 (Art. 32 Abs. 2 Bst. a HMG)

Company fined for illegal advertising of migraine medication.

This provision prohibits public advertising for prescription-only medicines, which was the primary basis for deeming the article impermissible advertising.

C-1080/2022 (Art. 32 Abs. 2 Bst. a HMG)

Company Brochure's Detailed Drug Information Deemed Impermissible Public Advertising

This provision establishes that advertising for prescription-only medicines is prohibited, forming the legal basis for the finding that the brochure's content constituted unlawful public advertising.

C-2987/2021 (Art. 32 Abs. 1 Bst. a und b HMG)

Magazine's Pharmaceutical Advertising Violated Regulations

These provisions were applied to find that the article constituted inadmissible advertising due to being unbalanced, incomplete, and unobjective.

C-2987/2021 (Art. 32 Abs. 2 Bst. a HMG)

Magazine's Pharmaceutical Advertising Violated Regulations

This provision was applied to find that the article violated the prohibition of public advertising for prescription-only medicines.

C-2798/2020 (Art. 32 Abs. 1 Bst. a und b HMG)

Swissmedic vs. "Alcohol-free" and "Nature's Healing Powers" Claims

Basis for prohibiting misleading advertising and advertising that could lead to excessive or inappropriate use of medicines.

C-5490/2015 (Art. 32 Abs. 1 Bst. a HMG)

Pharmaceutical Advertising Violations: Misleading Pregnancy Claims

This provision prohibits misleading advertising, and was violated by the advertising claims found to be misleading.

C-5490/2015 (Art. 32 Abs. 1 Bst. b HMG)

Pharmaceutical Advertising Violations: Misleading Pregnancy Claims

This provision prohibits advertising that could lead to excessive, abusive, or inappropriate use of medicines, and was violated as the advertising claims could lead to such use.

C-3090/2014 (Art. 32 Abs. 1 Bst. c HMG)

Pharma Co. v. Advertising Regulations (Tick Repellent & Unapproved Drugs)

Used to prohibit the advertising of medicines that are not permitted to be placed on the market in Switzerland.

C-5023/2013 (Art. 32 Abs. 1 Bst. b HMG)

Federal Administrative Court upholds advertising restrictions on apothecary's products, but overturns moot prohibition on unapproved content.

Cited as a basis for prohibiting the use of the term 'Bestseller' in advertising for medicinal products, as it could lead to excessive, abusive, or inappropriate use.

C-5023/2013 (Art. 32 Abs. 1 Bst. c HMG)

Federal Administrative Court upholds advertising restrictions on apothecary's products, but overturns moot prohibition on unapproved content.

Implicitly used to justify the prohibition of advertising for medicinal products that are not approved in Switzerland.

C-546/2010 (Art. 32 Abs. 2 Bst. a HMG)

Swissmedic v. Aesthetics Company: Advertising Ban and Website Modifications

Cited as the legal basis for prohibiting public advertising of prescription-only medicines.

C-1795/2009 (Art. 32 Abs. 2 Bst. a HMG)

Regulatory Order on Botox and Vistabel Advertising Partially Overturned

This provision prohibits public advertising for prescription-only medicines, which was the basis for the court's decision regarding the advertising of Botox and Vistabel.

C-3441/2007 (Art. 32 Abs. 2 Bst. a HMG)

Pharmaceutical Company Website Access Restrictions

Prohibits public advertising for prescription-only medicines.

C-4173/2007 (Art. 32 Abs. 2 Bst. a HMG)

Online Prescription Drug Advertising: Password Protection Required

Cited as the prohibition against public advertising for prescription-only medicines, which forms the core issue of the case.